What is a stock summary page? Click here for an overview.
Business Description
Senzime AB
NAICS : 339112
SIC : 3841
ISIN : SE0002478776
Compare
Compare
Traded in other countries / regions
SEZI.SwedenSNZZF.USA6YC.Germany IPO Date
2016-11-21Description
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.45 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.24 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.37 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 40.3 | |||||
| 3-Year EBITDA Growth Rate | 12.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.1 | |||||
| 3-Year FCF Growth Rate | 8 | |||||
| 3-Year Book Growth Rate | 3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.12 | |||||
| 9-Day RSI | 3.47 | |||||
| 14-Day RSI | 12.05 | |||||
| 3-1 Month Momentum % | -0.38 | |||||
| 6-1 Month Momentum % | -11.02 | |||||
| 12-1 Month Momentum % | -9.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4 | |||||
| Quick Ratio | 3.24 | |||||
| Cash Ratio | 2.76 | |||||
| Days Inventory | 232.49 | |||||
| Days Sales Outstanding | 68.71 | |||||
| Days Payable | 66.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.1 | |||||
| Shareholder Yield % | -13.51 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.41 | |||||
| Operating Margin % | -212.14 | |||||
| Net Margin % | -203.03 | |||||
| FCF Margin % | -215.79 | |||||
| ROE % | -35.36 | |||||
| ROA % | -29.44 | |||||
| ROIC % | -40.5 | |||||
| 3-Year ROIIC % | -16.93 | |||||
| ROC (Joel Greenblatt) % | -371.97 | |||||
| ROCE % | -32.42 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.23 | |||||
| PB Ratio | 1.89 | |||||
| Price-to-Tangible-Book | 7 | |||||
| EV-to-EBIT | -4.72 | |||||
| EV-to-Forward-EBIT | -9.07 | |||||
| EV-to-EBITDA | -6.01 | |||||
| EV-to-Forward-EBITDA | -12 | |||||
| EV-to-Revenue | 9.82 | |||||
| EV-to-Forward-Revenue | 8.57 | |||||
| EV-to-FCF | -4.55 | |||||
| Price-to-GF-Value | 0.49 | |||||
| Price-to-Median-PS-Value | 0.09 | |||||
| Price-to-Net-Current-Asset-Value | 9.8 | |||||
| Price-to-Net-Cash | 24.5 | |||||
| Earnings Yield (Greenblatt) % | -21.19 | |||||
| FCF Yield % | -19.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SNZZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Senzime AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.566 | ||
| EPS (TTM) ($) | -0.092 | ||
| Beta | -0.01 | ||
| 3-Year Sharpe Ratio | -0.42 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 28.12 | ||
| 14-Day RSI | 12.05 | ||
| 14-Day ATR ($) | 0.001472 | ||
| 20-Day SMA ($) | 0.49875 | ||
| 12-1 Month Momentum % | -9.48 | ||
| 52-Week Range ($) | 0.49 - 0.825 | ||
| Shares Outstanding (Mil) | 133.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Senzime AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Senzime AB Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Senzime AB Frequently Asked Questions
What is Senzime AB(SNZZF)'s stock price today?
The current price of SNZZF is $0.49. The 52 week high of SNZZF is $0.83 and 52 week low is $0.49.
When is next earnings date of Senzime AB(SNZZF)?
The next earnings date of Senzime AB(SNZZF) is 2025-05-07.
Does Senzime AB(SNZZF) pay dividends? If so, how much?
Senzime AB(SNZZF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers